Targeted Medical Pharma, Inc.
SEC CIK 1420030 · TRGM · last insider filing 2016-04-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Wenkart Thomas Richard | Director | filed 2014 - 2016 |
| Dewald Maurice J | Director | filed 2011 - 2016 |
| Giffoni Kim | Director · EVP Foreign Sales/Inv. Rel. | filed 2011 - 2016 |
| Silver David Samuel | Director · See Remarks | filed 2011 - 2016 |
| Weems Kerry Neil | Director | filed 2012 - 2016 |
| Shell William | Director · CEO/Chief Scientific Officer | filed 2011 - 2014 |
| Elizabeth Charuvastra Exemption Trust | Director · CEO & Chief Scientific Officer | filed 2014 - 2014 |
| Nemiroff Arthur R. | Director | filed 2011 - 2013 |
| Gottlieb Scott | Director | filed 2013 - 2013 |
| Webster Donald J. | Director | filed 2011 - 2013 |
| Heshmatpour Amir F | Director · President, Secretary | filed 2008 - 2012 |
| Bluher John H | Director | filed 2011 - 2011 |
| Charuvastra Elizabeth | Director · Chairman & VP Reg. Affairs | filed 2011 - 2011 |
| Brasel Timothy | Director · Vice President | filed 2010 - 2010 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Horne William B. | Chief Financial Officer | filed 2013 - 2016 |
| Blachman Amir | VP of Strategy and Operations | filed 2011 - 2014 |
| Rudolph Ronald W | See remarks | filed 2011 - 2012 |
| Warnecke Steve B | Chief Financial Officer | filed 2011 - 2011 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.